Filing Flows › Comparisons › APMD vs ABEO
Apnimed vs Abeona Therapeutics: APMD and ABEO compared
Apnimed is the larger company: $12.1M of revenue in its latest quarter (Q2 2026) against $11.4M for Abeona Therapeutics (Q2 2026). Abeona Therapeutics is growing faster (28× against -29% a year earlier). Apnimed is more profitable, with an operating margin of -96.9% against -120.0%.
Where the money goes: APMD and ABEO
Apnimed (APMD) · Q2 2026
Apnimed, Q2 2026: revenue $12.1M (-29% year over year), operating margin -96.9%, net earnings $126M. The chart follows the revenue to costs, profit and cash.
Abeona Therapeutics (ABEO) · Q2 2026
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
| Apnimed (APMD) | Abeona Therapeutics (ABEO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $12.1M | $11.4M |
| Revenue growth, Y/Y | -29% | 28× |
| Operating margin | -96.9% | -120.0% |
| Net earnings | $126M | −$20.2M |
| Net margin | — | -177.4% |
| Operating cash flow | — | −$17.5M |
Questions
Which is bigger, Apnimed or Abeona Therapeutics?
Apnimed is the larger company: $12.1M of revenue in its latest quarter (Q2 2026) against $11.4M for Abeona Therapeutics (Q2 2026).
Is Apnimed or Abeona Therapeutics growing faster?
Abeona Therapeutics is growing faster (28× against -29% a year earlier).
Which is more profitable, Apnimed or Abeona Therapeutics?
Apnimed is more profitable, with an operating margin of -96.9% against -120.0%.
More: Apnimed earnings · how Apnimed makes money · Abeona Therapeutics earnings · how Abeona Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Sep 8, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.